ID Karpas-25 AC CVCL_2540 SY KARPAS-25; Karpas 25; KARPAS 25; Karpas25 DR ECACC; 06072601 DR Wikidata; Q54899494 DR Ximbio; 152420 RX CelloPub=CLPUB00604; RX PubMed=10936422; RX PubMed=15621787; RX PubMed=32123307; WW Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines WW Provider; Cambridge Enterprise; -; https://www.enterprise.cam.ac.uk/reagents/karpas-25-human-myeloma-cell-line/ CC Doubling time: ~30 hours (ECACC=06072601; Ximbio=152420). CC Omics: Transcriptomics; RNAseq. CC Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. CC Cell type: Plasma cell; CL=CL_0000786. DI NCIt; C3242; Plasma cell myeloma DI ORDO; Orphanet_29073; Multiple myeloma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 27Y CA Cancer cell line DT Created: 04-04-12; Last updated: 14-08-25; Version: 18 // RX PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2; RA Drexler, Hans Gunther RA Matsuo, Yoshinobu RT "Malignant hematopoietic cell lines: in vitro models for the study of RT multiple myeloma and plasma cell leukemia."; RL Leuk. Res. 24:681-703(2000). // RX CelloPub=CLPUB00604; RA Chow, Sharon RT "Targeted capture and sequencing of immunoglobulin rearrangements RT in multiple myeloma to enable detection of minimal residual disease."; RL Thesis MSc (2017); University of Toronto; Toronto; Canada. // RX PubMed=32123307; DOI=10.1038/s41375-020-0785-1; PMCID=PMC7483300; RA Sarin, Vishesh RA Yu, Katharine RA Ferguson, Ian D. RA Gugliemini, Olivia RA Nix, Matthew A. RA Hann, Byron RA Sirota, Marina RA Wiita, Arun P. RT "Evaluating the efficacy of multiple myeloma cell lines as models for RT patient tumors via transcriptomic correlation analysis."; RL Leukemia 34:2754-2765(2020). // RX PubMed=15621787; DOI=10.1080/10428190400002244; RA Karpas, Abraham RA Harder, Lana RA Czepulkowski, Barbara H. RA Bloxham, David RA Saward, Rani RA Dremucheva, Alla RA Siebert, Reiner RT "Studies of four new human myeloma cell lines."; RL Leuk. Lymphoma 46:101-112(2005). //